Scholarlink

<p>Phosphorothioate oligonucleotides (PS-ODNs) and cyclic dinucleotides are important therapeutic agents whose activity depends critically on phosphorus stereochemistry. However, existing strategies largely rely on chiral auxiliaries that require multistep installation and removal. Although chiral phosphoric acid catalysis enables diastereoselective synthesis of P-stereogenic dinucleotides via P(III)-phosphoramidite chemistry, this approach fails to access long-chain stereodefined PS-ODNs. Here we report a catalytic asymmetric P(V)-based strategy that enables stereocontrolled synthesis of PS-ODNs and cyclic dinucleotides using chiral organocatalysts. This platform integrates a catalyst-controlled nucleoside loading step with a stereospecific coupling process under mild, redox-neutral conditions. The method exhibits broad substrate scope, enabling efficient construction of diverse P–O, P–S, P–C and P–N linkages with high stereochemical fidelity. Notably, the method enables the stereocontrolled synthesis of PS-ODNs under both 5′ → 3′ and standard 3′ → 5′ solid-phase oligonucleotide synthesis workflows. Mechanistic studies support a cooperative activation mode involving hydrogen bonding, nucleophilic activation and general base catalysis.</p><p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Multifunctional chiral bis(amidine) organocatalysts enable stereoselective synthesis of phosphorothioate oligonucleotides

  • 期刊论文

  • 发表日期：

    2026年8月5日

查看全文
  • Shuai-Shuai Fang,
  • Guo-Dong Sun,
  • Jia-Wei Liu,
  • Ming-Hong Li,
  • Tian Xie,
  • Kang-Ning Yuan,
  • Hong-Qing Yao,
  • Yue-Ming Cai,
  • Chunhai Fan,
  • Ming Shang

摘要

Phosphorothioate oligonucleotides (PS-ODNs) and cyclic dinucleotides are important therapeutic agents whose activity depends critically on phosphorus stereochemistry. However, existing strategies largely rely on chiral auxiliaries that require multistep installation and removal. Although chiral phosphoric acid catalysis enables diastereoselective synthesis of P-stereogenic dinucleotides via P(III)-phosphoramidite chemistry, this approach fails to access long-chain stereodefined PS-ODNs. Here we report a catalytic asymmetric P(V)-based strategy that enables stereocontrolled synthesis of PS-ODNs and cyclic dinucleotides using chiral organocatalysts. This platform integrates a catalyst-controlled nucleoside loading step with a stereospecific coupling process under mild, redox-neutral conditions. The method exhibits broad substrate scope, enabling efficient construction of diverse P–O, P–S, P–C and P–N linkages with high stereochemical fidelity. Notably, the method enables the stereocontrolled synthesis of PS-ODNs under both 5′ → 3′ and standard 3′ → 5′ solid-phase oligonucleotide synthesis workflows. Mechanistic studies support a cooperative activation mode involving hydrogen bonding, nucleophilic activation and general base catalysis.